Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| With the improvements in our operating cash flow achieved in 2023 cash proceeds receipts received from the sale of BioTrack and to make minority investments, we feel we are well-positioned to capitalize incremental growth opportunities as they arise |
| Having achieved a positive EBITDA contribution in the last two quarters we also expect to report a positive EBITDA contribution for the year as we continue to leverage our infrastructure |
| We're pleased to report strong third-quarter performance |
| We recorded strategic new wins across a variety of different types of clients and are happy to report that we see increased momentum within the large pharmaceutical manufacturer segment |
| In conclusion, it was a productive and efficient third quarter where we delivered solid results and added assets to further strengthen Forian's long-term business despite operating in the same challenging macroeconomic sales environment as previously reported, while we believe the headwinds are temporary, we expect 2023 revenues to be within the previously issued guidance range of 20.5 million to 22.5 million |
| On the top line our consolidated revenue grew 24% on a year-over-year basis in the third quarter to $5.3 million and as a result of our continued efforts to drive margin improvements, our net income and consolidated adjusted EBITDA of $4.3 million and $755,000 respectively, continued to improve |
| The improvement in our adjusted EBITDA margins were driven by a combination of strong leverage over the cost structure, improved efficiency and a contribution from recurring contracts, which we believe demonstrates the scalability that inherent in the business model |
| The combination of positive adjusted EBITDA and the strategic access has improved our balance sheet |
| I'm proud of our team in achieving these results |
| Our results reflect the operating scalability and strength of our young business in our success in improving our positive contribution to our clients as the healthcare landscape continues to evolve towards greater dependent on timely Healthcare Information Solutions, stakeholders access to comprehensive longitudinal health care information to drive insights built to improve health outcomes and business performance is more imperative than ever |
| First, our third quarter results strengthen an already solid balance sheet that distinguishes us across the industry and especially from other earlier stage companies |
| Adjusted EBITDA from continuing operations, which excludes stock-based compensation, depreciation, amortization and certain other nonrecurring items, was positive $800,000 compared to negative $1.2 million in the same quarter last year, again, demonstrating the operating leverage in our streamline business |
| Collectively, these new data assets further differentiate our offerings and will lead the development of unique information solutions in the coming quarters |
| In the third quarter we saw strength across key offerings in customer types |
| The growth in revenue over the same quarter of last year was driven by both new customers and increased revenues from our existing relationships |
| As a reminder, the majority of our information contracts provide for continuing information deliverables to our customers over a multiyear period, providing a predictable recurring revenue stream on a going-forward basis |
| We expect to continue to differentiate Forian from our competition through the breadth of our data science-based offerings, leading health care expertise and engaging customer service |
| The improvement in loss from continuing operations resulted from the $1 million of revenue growth discussed above and a $1 million reduction in costs and expenses |
| We believe there is a large market opportunity for Forian to provide and enable key insights on what is really happening in the health care market today, and we plan to continue to disrupt certain staff close and to win business from larger competitors |
| These developments tie well with my second point regarding the steps we are taking to further differentiate ourselves as a trusted partner Forian is continuing to cost effectively add breadth and scale to our unique integrated the identified data factory |
| Second, Forian is becoming synonymous with a trusted health care information partner, we are taking additional concrete steps to further differentiate our business and offerings by onboarding complementary and unique new data assets, while developing analytics that deliver mission critical value to our clients |
| Our consolidated revenues of $5.3 million for the quarter were up $1 million or 24% compared to the same quarter last year |
| Net income from continuing operations for the quarter increased $8.4 million from the same quarter last year to $5.4 million |
| While we intend to make incremental investments in our information infrastructure to enhance and expand our product offerings, we also expect our capital-efficient business model to allow us to continue to leverage those investments with a lower level of expense growth relative to revenue over the long term |
| In my prepared comments this afternoon, I have focused on two key themes that reflect the value we're delivering today and are poised to deliver in the years ahead |
| The Forian data factory has been designed to ingest, normalize, anonymize and enable analytic ready information with greater quality and efficiency than our competition |
| We expect 2023 revenues to be within the previously issued guidance range of $20.5 million to $22.5 million, reflecting an increase in excess of 25% over the prior year health care information revenues |
| We find ourselves in an advantageous position where our cash position differentiates us from other companies that are struggling to generate a profit or raise additional funds in their currently challenged growth, equity and capital markets |
| Thank you, everybody |
| The increase in net income was primarily driven by a $5.8 million gain on sale of investment and a decrease in loss from continuing operations of $2 million, which was partially offset by changes in other income items such as interest and income taxes |
| Statement |
|---|
| There is, therefore, a significant risk that actual results could differ materially from the outlook provided today |
| And just also, have you guys experienced any new attrition due to some customers being acquired?I know that in the past that's been something -- that's something you have to work through |
| Through this transaction and the previous dispositions of our Engeni and Security Grade businesses, Forian no longer provides software solutions to the cannabis industry, representing a strategic shift, which has a significant impact on operations |
| Estimating financial performance accurately for future performance is difficult as it involves assumptions and internal estimates that may prove to be incorrect and is based on plans and circumstances that may change |
| Actual results may differ materially from those indicated by those forward-looking statements due to a variety of important factors, including those discussed in the Risk Factors section of the company's annual report on Form 10-K for the year ended December 31, 2022, as filed with the SEC on March 30, 2023 |
Please consider a small donation if you think this website provides you with relevant information